Luis Cabrera-Sosa

Luis Cabrera-Sosa

Auto-generated profile, based on publicly available information

Luis Cabrera-Sosa

Unit of Malariology, Biomedical Sciences Department, Institute of Tropical Medicine Antwerp , Antwerp

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020
Verified
Book Chapter
Closed access
LCLuis Cabrera-Sosa
Luis Cabrera-Sosa
TOTheresa J. Ochoa
Theresa J. Ochoa

1 November 2021 in STAR Protocols
Verified
Journal Article
Open access
GMGabriel Mendoza-Rojas
Gabriel Mendoza-Rojas
VSVanessa Sarabia-Vega
Vanessa Sarabia-Vega
ASAna Sanchez-Castro
Ana Sanchez-Castro
LTLesia Tello
Lesia Tello
LCLuis Cabrera-Sosa
Luis Cabrera-Sosa
PMPohl Milón
Pohl Milón
Here, we describe a detailed step-by-step protocol for the expression, purification, quantification, and activity determination of key enzymes for molecular detection of pathogens. Based on previous reports, we optimized the protocol for LbCas12a, Taq DNA polymerase, M-MLV reverse transcriptase, and TEV protease to make it compatible with minimal laboratory equipment, broadly available in low- and middle-income countries. The enzymes produced with this protocol have been successfully used for molecular detection applications.

29 April 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
EDEva Dueñas
Eva Dueñas
JNJose A. Nakamoto
Jose A. Nakamoto
LCLuis Cabrera-Sosa
Luis Cabrera-Sosa
PHPercy Huaihua
Percy Huaihua
MCMaría Cruz
María Cruz
Vanessa AdauiVanessa Adaui
Vanessa Adaui
Tegumentary leishmaniasis, a disease caused by protozoan parasites of the genus Leishmania , is a major public health problem in many regions of Latin America. Its diagnosis is difficult given other conditions resembling leishmaniasis lesions and co-occurring in the same endemic areas. A combination of parasitological and molecular methods lead to accurate diagnosis, with the latter being traditionally performed in centralized reference and research laboratories as they require specialized infrastructure and operators. CRISPR-Cas systems have recently driven innovative tools for nucleic acid detection that combine high specificity, sensitivity and speed and are readily adaptable for point-of-care testing. Here, we harnessed the CRISPR-Cas12a system for molecular detection of Leishmania spp., emphasizing medically relevant parasite species circulating in Peru and other endemic areas in Latin America, with L . ( Viannia ) braziliensis being the main etiologic agent of cutaneous and mucosal leishmaniasis. We developed two assays targeting multi-copy targets commonly used in the molecular diagnosis of leishmaniasis: the 18S ribosomal RNA gene (18S rDNA), highly conserved across Leishmania species, and a region of kinetoplast DNA (kDNA) minicircles conserved in the L . ( Viannia ) subgenus. Our CRISPR-based assays were capable of detecting down to 5 × 10 −2 (kDNA) or 5 × 10 0 (18S rDNA) parasite genome equivalents/reaction with PCR preamplification. The 18S PCR/CRISPR assay achieved pan- Leishmania detection, whereas the kDNA PCR/CRISPR assay was specific for L . ( Viannia ) detection. No cross-reaction was observed with Trypanosoma cruzi strain Y or human DNA. We evaluated the performance of the assays using 49 clinical samples compared to a kDNA real-time PCR assay as the reference test. The kDNA PCR/CRISPR assay performed equally well as the reference test, with positive and negative percent agreement of 100%. The 18S PCR/CRISPR assay had high positive and negative percent agreement of 82.1% and 100%, respectively. The findings support the potential applicability of the newly developed CRISPR-based molecular tools for first-line diagnosis of Leishmania infections at the genus and L . ( Viannia ) subgenus levels.

26 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
IGIsabela Gerdes Gyuricza
Isabela Gerdes Gyuricza
AFAbebe A. Fola
Abebe A. Fola
ASAlfred Simkin
Alfred Simkin
KTKyaw L. Thwai
Kyaw L. Thwai
JJJonathan J. Juliano
Jonathan J. Juliano
JPJonathan B. Parr
Jonathan B. Parr
Plasmodium falciparum parasites with deletions of the histidine-rich protein 2 and 3 ( hrp2 and hrp3 ) genes evade detection by common rapid diagnostic tests (RDTs) and pose a growing threat to malaria control. While these deletions have emerged in multiple regions globally, the evolutionary forces driving their spread remain unclear. Here, we analyze 1,215 P. falciparum samples collected between 2003 and 2018 in Loreto, Peru. This region experienced a major decline in malaria transmission following the Project for Malaria Control in Andean Border Areas (PAMAFRO) and now harbors a high proportion of hrp2/3 deleted parasites despite limited RDT use. Using molecular inversion probe (MIP) sequencing across > 2,000 genome-wide loci, we observed a marked reduction in genetic diversity, increased clonality, and fixation of parasites with deletions of both hrp2 and hrp3 genes ( hrp2-/3- ) over time. Identity-by-descent (IBD) analysis revealed rapid expansion of a single hrp2-/3- dominant lineage in the post-PAMAFRO period, consistent with clonal replacement after intense malaria control. Targeted sequencing of the hrp2/3 regions showed conserved deletion breakpoints across three different lineages, indicative of recombination of a common haplotype into distinct genetic backgrounds. To investigate the evolutionary forces driving the fixation of hrp2-/3- in Loreto, we simulated allele frequency trajectories under different selection coefficients. We found that fixation of hrp2-/3- due solely to genetic drift (selection coefficient s = 0) is unlikely; a selection coefficient of s ≥ 0.03 was required for fixation to occur consistently. However, our simulations also indicate that a genetic bottleneck caused by PAMAFRO increased the likelihood of fixation through drift by 4.5- to 17-fold depending on the population. These findings suggest that hrp2-/3- fixation was likely driven by a combination of demographic changes resulting from PAMAFRO and selective advantage unrelated to RDT use. Our results demonstrate how intensive malaria control efforts can reshape parasite populations and underscore the value of expanded genomic surveillance as countries move toward malaria elimination.

9 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
LCLuis Cabrera-Sosa
Luis Cabrera-Sosa
MSMahdi Safarpour
Mahdi Safarpour
JKJohanna H. Kattenberg
Johanna H. Kattenberg
RRRoberson Ramirez
Roberson Ramirez
JVJoseph Vinetz
Joseph Vinetz
CDChristopher Delgado-Ratto
Christopher Delgado-Ratto
Malaria molecular surveillance (MMS) can provide insights into transmission dynamics, guiding national control/elimination programs. Considering the genetic differences among parasites from different areas in the Peruvian Amazon, we previously designed SNP barcode panels for Plasmodium vivax (Pv) and P. falciparum (Pf), integrated into AmpliSeq assays, to provide population genetics estimates of malaria parasites. These AmpliSeq assays are ideal for MMS: multiplexing different traits of interest, applicable to many use cases, and high throughput for large numbers of samples. The present study compares the genetic resolution of the SNP barcode panels in the AmpliSeq assays with widely used microsatellite (MS) panels to investigate Amazonian malaria parasites. Malaria samples collected in remote areas of the Peruvian Amazon (51 Pv & 80 Pf samples) were characterized using the Ampliseq assays and MS. Population genetics estimates (complexity of infection, genetic diversity and differentiation, and population structure) were compared using the SNP barcodes (Pv: 40 SNPs & Pf: 28 SNPs) and MS panels (Pv: 16 MS & Pf: 7 MS). The genetic diversity of Pv (expected heterozygosity, He ) was similar across the subpopulations for both makers: He MS = 0.68 - 0.78 (p = 0.23) and He SNP = 0.36 - 0.38 (p = 0.80). Pairwise genetic differentiation (fixation index, F ST ) was also comparable: F ST-MS = 0.04 - 0.14 and F ST-SNP = 0.03 - 0.12 (p = 0.34 – 0.85). No geographic clustering was observed with any panel. In addition, Pf genetic diversity trends ( He MS = 0 – 0.48 p = 0.03 – 1; He SNP = 0 - 0.09, p = 0.03 – 1) and pairwise F ST comparisons (F ST-MS = 0.14 – 0.65, F ST-SNP = 0.19 – 0.61, p = 0.24 – 0.83) were concordant between the panels. Similar population structure clustering was observed with both SNP and MS, highlighting one Pf subpopulation in an indigenous community. The SNP barcodes in the Pv AmpliSeq v2 Peru and Pf AmpliSeq v1 Peru assays offer comparable results to MS panels when investigating population genetics in Pv and Pv populations. Therefore, the AmpliSeq assays can efficiently characterize malaria transmission dynamics and population structure and support malaria elimination efforts in Peru.

13 August 2026 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
WLWinni A Ladeia
Winni A Ladeia
NANathalia Rammé M de Albuquerque
Nathalia Rammé M de Albuquerque
Igor Cavallini JohansenIgor Cavallini Johansen
Igor Cavallini Johansen
RCRodrigo M Corder
Rodrigo M Corder
PRPriscila T Rodrigues
Priscila T Rodrigues
MCMarcia C Castro
Marcia C Castro
Background: Despite continued control efforts, malaria due to Plasmodium vivax and Plasmodium falciparum remains endemic across the Amazon Basin. Here, we sought to understand how malaria parasites spread between sources and sinks within the upper Juruá Valley region of northwestern Brazil, the country's main residual transmission hotspot, to inform more effective control and elimination strategies. Methods: We combined the analysis of nearly 70 000 case notifications between 2018 and 2021 with high-resolution molecular genotyping data from 207 P. vivax and 117 P. falciparum isolates to map malaria parasite movement across the Juruá Valley hotspot. We introduce the C50 metric to estimate parasite connectivity within clusters of genetically related parasites, or molecular clusters. Results: We found that 16%–18% of infections were acquired outside participants’ localities of residence. Genotyping of P. vivax and P. falciparum revealed large molecular clusters comprising parasites of each species collected across rural–urban boundaries over 4 years, with some pairs of genetically related parasites originating from distant localities within Juruá Valley. We found a large variation in C50 values, with a few parasites serving as main hubs within molecular clusters. Imported P. vivax isolates were significantly more connected than locally acquired infections. Conclusions: We suggest that the combined use of routine epidemiological surveillance data and molecular genotyping can help to map human mobility and parasite lineage dispersal across space and time, aiming to inform specific interventions tailored for local populations that move malaria parasites between source and sink localities in residual transmission settings in the Amazon.